DMI Acquisition Corp.
8Patents
7Active
8Granted
44Portfolio score
Filing activity: Mar 25, 2003 → Nov 14, 2012 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8217047B2 | Therapeutic methods and compounds | Human Necessities | 27 | Active |
| US8507496B2 | Treatment of diseases | Emerging Cross-Sectional Technologies | 27 | Active |
| US8440696B2 | Method of using diketopiperazines and composition containing them | Human Necessities | 22 | Active |
| US8455517B2 | Method of using diketopiperazines and composition containing them | Human Necessities | 22 | Expired |
| US8513196B2 | Treatment of T-cell mediated diseases | Chemistry; Metallurgy | 17 | Active |
| US8551953B2 | Treatment of T-cell mediated diseases | Chemistry; Metallurgy | 17 | Active |
| US8227457B2 | Method for treatment of diseases | Human Necessities | 4 | Active |
| US8507651B2 | Treatment of diseases and conditions mediated by increased phosphorylation | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.